Skip to content

Study · Non-randomized trial · n = 418 · 1996

2 results

[Hemodilution therapy with neuron metabolism specific therapy in ischemic stroke--encouraging results of a comparative study].

Koppi S, Barolin GS

Wiener medizinische Wochenschrift (1946)1 Jan 1996Cited by 5 (Europe PMC)

PMID8867272 (opens in a new tab)PepBankPUB-08867272
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In ischemic stroke patients, adding Cerebrolysin to hemodilution treatment improved rehabilitation scale outcomes compared with hemodilution alone.

    In plain wordsIn stroke patients, adding Cerebrolysin improved rehabilitation scale outcomes compared with hemodilution treatment alone.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseBarolin-Neuro-Rehabilitation Scale outcome
    Study

    n = 418

    Comparator
    Same hemodilution treatment without Cerebrolysin
    Outcome group
    Exercise and physical function · Nervous system and cognition
    Studied dose
    Dose not stated

    Measurements

    Control group size
    318 patients
    Hemodilution therapy without Cerebrolysin
    Treatment group size
    100 patients
    Same hemodilution treatment with add-on Cerebrolysin

    Source sentences

    Summary
    It proved a statistically validated better outcome within the Cerebrolysin add-on treated group evaluated by the Barolin-Neuro-Rehabilitation Scale.
    2 context sentences
    Summary · context
    Treating ischemic stroke we could compare a (control-)group of 318 patients under up to date hemodilution therapy
    Summary · context
    to a group of 100 patients receiving exactly the same treating scheme but including an add-on administering of Cerebrolysin.
  2. 02HumanNon-randomized trialEfficacy outcome

    In ischemic stroke patients, adding Cerebrolysin to hemodilution had more effect on social and occupational parameters than on motor functions, though some motor functions were also affected, compared with hemodilution alone.

    In plain wordsIn stroke patients, adding Cerebrolysin to hemodilution had more effect on social and work measures than on motor function, compared with hemodilution alone.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseSocial and occupational parameters
    Study

    n = 418

    Comparator
    Same hemodilution treatment without Cerebrolysin
    Outcome group
    Exercise and physical function · Nervous system and cognition
    Studied dose
    Dose not stated

    Measurements

    Control group size
    318 patients
    Hemodilution therapy without Cerebrolysin
    Treatment group size
    100 patients
    Same hemodilution treatment with add-on Cerebrolysin

    Source sentences

    Summary
    1) More effect on social and occupational parameters than on motor functions, but also including some of those.
    3 context sentences
    Summary · context
    It proved a statistically validated better outcome within the Cerebrolysin add-on treated group evaluated by the Barolin-Neuro-Rehabilitation Scale.
    Summary · context
    Treating ischemic stroke we could compare a (control-)group of 318 patients under up to date hemodilution therapy
    Summary · context
    to a group of 100 patients receiving exactly the same treating scheme but including an add-on administering of Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.